# A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis

> **NCT02682238** · PHASE2 · COMPLETED · sponsor: **Botanix Pharmaceuticals** · enrollment: 50 (actual)

## Conditions studied

- Hyperhidrosis

## Interventions

- **DRUG:** BBI-4000, 15%
- **OTHER:** Vehicle gel

## Key facts

- **NCT ID:** NCT02682238
- **Lead sponsor:** Botanix Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-08
- **Primary completion:** 2016-07-14
- **Final completion:** 2016-10-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682238, "A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT02682238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*